Telomerase plays a pivotal role in stem cell function and longevity. It is an enzyme that adds repetitive nucleotide sequences to the ends of chromosomes (telomeres), thereby preventing chromosomal degradation during cell division. In most somatic cells, telomerase activity is low or absent, leading to gradual telomere shortening and eventual cellular ageing or apoptosis. However, in stem cells, telomerase activity is higher, enabling these cells to divide repeatedly and maintain their integrity over time. This sustained telomerase activity is crucial for the long-term self-renewal capacity of stem cells and is a key factor in their ability to perpetuate tissue regeneration throughout an organism's life.

Stem cells can indeed be used in gene therapy, and they offer a promising approach for treating genetic disorders. In this context, stem cells are genetically modified to carry a normal copy of a defective gene. The process involves extracting stem cells from the patient, using viral vectors or other methods to introduce the therapeutic gene into these cells, and then reintroducing the modified stem cells back into the patient. These stem cells then proliferate and differentiate, producing new cells that express the functional gene. This approach is particularly effective in blood disorders like sickle cell anaemia, where modified hematopoietic stem cells can produce healthy red blood cells.

Stem cell therapies, while promising, carry several risks, especially in transplantation scenarios. One major risk is the potential for the development of tumours, as some stem cells, particularly embryonic stem cells, can proliferate uncontrollably. There's also a risk of immune rejection, where the recipient's immune system attacks the transplanted cells, although this risk is lower with autologous transplants (using the patient's own stem cells). Additionally, infections and complications related to the procedure itself can occur. There's also the concern of unintended differentiation, where stem cells may develop into an unwanted cell type, potentially causing harm.

While induced pluripotent stem cells (iPSCs) alleviate some ethical concerns associated with embryonic stem cells (ESCs), such as the destruction of embryos, they are not without their own ethical issues. One concern with iPSCs is the potential for their use in reproductive cloning, although this is more of a theoretical concern at present. Another issue is the source of the adult cells used to create iPSCs, which requires informed consent, especially when using cells from donors. Additionally, there are concerns about the long-term effects of reprogramming cells, including the potential for genetic mutations or tumorigenicity, raising questions about the safety and ethical implications of their use in therapies.

Stem cells play a crucial role in the body's natural healing process by replenishing and repairing tissues. When an injury occurs, signals from the damaged area attract stem cells to the site. These stem cells then differentiate into the specific cell types needed for repair. For example, in bone fractures, stem cells migrate to the injury site and differentiate into osteoblasts (bone-forming cells), facilitating the repair and regeneration of bone tissue. This process is vital in maintaining the body's integrity and function, as it enables the continuous replacement of cells lost due to injury, wear and tear, or ageing.